Resultados de la búsqueda 51-60 of 2849 for Hormone Horizons
... hormonal factors associated with onset of symptoms in MSA. Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in ...
... estrogen and progesterone receptor (ER and PR) all negative], HER2 positive ... cycle, if necessary delayed until all clinical parameters are acceptable to ...
Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients ...
Page 1.
This study will include some patients receiving the hormone therapy and some patients who are not, so we can better understand whether patients getting the ...
... estrogen and progesterone receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced ...
Rochester, Minn. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or ...
This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor ...
Rochester, Minn. Congenital heart disease (CHD) is an abnormal formation that occurs during the development of a baby's heart, heart valves and/or large vessels ...
The purpose of this study is to evaluate whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.